治疗大肝癌的近期疗效与安全性分析[J].医学影像学杂志,2017,27(4):677-681.[5]FacciorussoA,DiMasoM,MuscatielloN.Drug-elutingbeadsversusconventionalchemoembolizationforthetreatmentofunre-sectablehepatocellularcarcinoma:ameta-analysis[J].DigLiv-erDis,2016,48(6):571-577.[6]陈刚,张鼎,应亚草,等.国产载药微球经动脉化疗栓塞治疗不可切除原发性肝癌的临床研究[J].浙江大学学报:医学版,2017,46(1):44-51.[7]TakaySU,AriiS.Superselectivetransarterialchemoembolizationforhepatocellularcarcinomavalidationoftreatmentalgorithmpro-posedbyjapaneseguidelines[J].JHepatol,2012,56(4):886-892.[8]TerziE,PpiscagliaF,ForlaniL,etal.TACEperformedinpa-tientswithasinglenoduleofHepatocellularCarcionma[J].BMCCancer,2014,14(1):601-614.[9]FerrerP,ParraC,EstebanE,etal.Comparisonofdoxorubicin-elutingbeadtransarterialchemoembolization(DEB-TACE)withconventionaltransarterialchemoembolization(TACE)forthetreatmentofhepatocellularcarcinoma[J].Radiologia,2011,53(3):246-253.[10]黄英杰,凌永志,秦梓良,等.HepaSphere载药微球治疗原发性肝癌的效果评价[J].临床医学,2018,38(1):35-36.[11]LammerJ,MalagariK,VoglT,etal.Prospectiverandomizedstudyofdoxorubicin-eluting-beadembolizationinthetreatmentofhepatocellularcarcinoma:resultsofthePECISIONVstudy[J].CardiovascInterventRadiol,2010,33(1):41-52.[12]徐鹏程,张庆桥,徐浩,等.CalliSpheres载药微球TACE联合微波消融治疗原发性大肝癌疗效评价[J].医学影像学杂志,2020,30(4):620-623.[13]MalagriK,PomoniM,KelekisA,etal.Prospectiverandomizedcomparisonofchemoembolizationwithdoxorubicin-elutingbeadsandblandembolizationwithBeadBlockforhepatocellularcarcino-ma[J].CardiovascInterventRadiol,2010,33(3):541-551.[14]ZouJH,ZhangL,RenZG,etal.EfficacyandsafetyofcTACEversusDEB-TACEinpatientswithhepatocellularcarcinoma:ameta-analysis[J].JournalofDigestiveDiseases,2016,17(8):510-517.[15]WiggermannP,SieronD,BroscheC,etal.Transarterialchemo-embolizationofChild-Ahepatocellularcarcinoma:drug-el...